Intuitive Surgical Inc. (ISRG)

In the Base scenario, representing the modal fundamental trajectory, Intuitive sustains steady procedural compounding consistent with corporate guidance. System placements in mature domestic markets tilt heavily toward trade-in upgrades rather than greenfield additions, while international expansion through tiered offerings partially balances public healthcare reimbursement delays. Normalized cash flows and cost of equity discounting yield a Base scenario target of $195.88 with a probability of 60.0% and an expected return of -51.7% against $405.18, aligning closely with the house Fair value of $195.88. This path would be disconfirmed by a sudden procedural volume contraction below double digits or by rapid multiple compression toward medtech peer medians.

• Procedure volumes expand in line with management full-year guided ranges
• Domestic system placements remain predominantly replacement trade-ins with moderating installed base expansion
• EndoWrist extended-use cycles introduce progressive procedural cost savings balanced by broader benign procedure penetration
• Operating margins normalize near guided baseline levels with gradual terminal multiple contraction